Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery

Clinical trial NCT05838846 · COMPLETED

Trial details

NCT number: NCT05838846
Sponsor: Menoufia University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mitral Valve Replacement Pulmonary Hypertension Inhaled Milrinone Intravenous Milrinone

Start date: 2023-04-01
Primary completion: 2025-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.